1. 3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. (September 2015) Authors: Urun, Y.; Abal, H.; Turna, H.; Esin, E.; Sedef, A.M.; Alkan, A.; Oksüzoğlu, B.; Ozdemir, N.Y.; Sendur, M.A.N.; Sezer, A.; Kiliçkap, S.; Akbulut, H.; Celik, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗